State Street Corporation 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-01 10:22 am Sale | 2022-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | STATE STREET CORP STT | 2,291,454 4.870% | -76,586 (-3.23%) | Filing |
| 2022-02-10 1:29 pm Purchase | 2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | STATE STREET CORP STT | 2,368,040 5.070% | 2,368,040 (New Position) | Filing |